More than 100 stakeholders from academia, industry, regulators and patients/patient associations attended our first Multi-Stakeholder Meeting (MSM) on April 14 and 15, 2021. Our first c4c MSM was held online and focused on Paediatric inflammatory Bowel Disease (IBD). There are multiple drugs in development for IBD, however several clinical trials, as part of agreed pediatric development plans, are attempting to enroll patients with limited success. Please find the report on the meeting here